Literature DB >> 19266408

Adherence to HAART: processes explaining adherence behavior in acceptors and non-acceptors.

Sigrid C J M Vervoort1, Mieke H F Grypdonck, Annelies de Grauwe, Andy I M Hoepelman, Jan C C Borleffs.   

Abstract

In order to explore and clarify the underlying processes which lead to (non)-adherence behavior in patients treated with highly active antiretroviral therapy (HAART), a qualitative study was conducted. Thirty-seven in-depth interviews were held with 30 Caucasian HIV-positive patients. Additional data were collected by diaries kept by some participants. The analysis took place in a cyclic process; selection of themes was alternated with input of new material. Adherence to HAART is mainly influenced by the experience of being HIV positive. Acceptance or non-acceptance of HIV leads to one of two basic stances toward adherence: "being determined to be adherent" or "medication is subordinate to other priorities in life". This stance determines the commitment to therapy and influences how patients cope with adherence. Patients who are determined to be adherent find solutions to adherence problems. Patients who are not determined to be adherent solve problems only if the solution does not compromise important aspects of their lives. Insight is provided into the manner in which prevalent themes; "start of HAART", "attitude toward medication", "HAART in daily life", "contextual factors", "health and HAART" and "being informed", influence adherence behavior. Before starting HAART the focus should be on helping the patient to accept HIV as a part of life. The findings need to be taken into account in adherence-promoting interventions.

Entities:  

Mesh:

Year:  2009        PMID: 19266408     DOI: 10.1080/09540120802290381

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  10 in total

1.  Brief screening for alcohol use disorders in HIV primary care.

Authors:  Julia M Holmes; Kelly R Gerhardstein; Phillip T Griffin
Journal:  HIV Clin       Date:  2011

Review 2.  Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time.

Authors:  Becky L Genberg; Yoojin Lee; William H Rogers; Ira B Wilson
Journal:  AIDS Behav       Date:  2015-01

3.  Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.

Authors:  Isabelle Krummenacher; Brenda Spencer; Sophie Du Pasquier; Olivier Bugnon; Matthias Cavassini; Marie P Schneider
Journal:  Int J Clin Pharm       Date:  2014-06-10

4.  Medication-Taking Practices of Patients on Antiretroviral HIV Therapy: Control, Power, and Intentionality.

Authors:  Kathryn E Muessig; Abigail T Panter; Mary S Mouw; Kemi Amola; Kathryn E Stein; Joseph S Murphy; Eric M Maiese; David A Wohl
Journal:  AIDS Patient Care STDS       Date:  2015-11       Impact factor: 5.078

5.  Psychosocial variables associated with coping of HIV-positive women diagnosed during pregnancy.

Authors:  Marinda Kotzé; Maretha Visser; Jenny Makin; Kathleen Sikkema; Brian Forsyth
Journal:  AIDS Behav       Date:  2013-02

6.  Plasma drug level validates self-reported adherence but predicts limited specificity for nonadherence to antiretroviral therapy.

Authors:  Robert Balikuddembe; Joshua Kayiwa; David Musoke; Muhammad Ntale; Steven Baveewo; Paul Waako; Celestino Obua
Journal:  ISRN Pharmacol       Date:  2012-03-06

7.  Coping profiles and subjective well-being among people living with HIV: less intensive coping corresponds with better well-being.

Authors:  Marcin Rzeszutek; Ewa Gruszczyńska; Ewa Firląg-Burkacka
Journal:  Qual Life Res       Date:  2017-06-05       Impact factor: 4.147

8.  Health-related quality of life and coping strategies among people living with HIV: the moderating role of gender.

Authors:  Marcin Rzeszutek
Journal:  Arch Womens Ment Health       Date:  2017-12-18       Impact factor: 3.633

Review 9.  The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis.

Authors:  Haochu Li; Gifty Marley; Wei Ma; Chongyi Wei; Mellanye Lackey; Qingyan Ma; Françoise Renaud; Marco Vitoria; Rachel Beanland; Meg Doherty; Joseph D Tucker
Journal:  AIDS Behav       Date:  2017-02

10.  The ACTonHEART study: rationale and design of a randomized controlled clinical trial comparing a brief intervention based on Acceptance and Commitment Therapy to usual secondary prevention care of coronary heart disease.

Authors:  Chiara A M Spatola; Gian Mauro Manzoni; Gianluca Castelnuovo; Gabriella Malfatto; Mario Facchini; Christina L Goodwin; Matteo Baruffi; Enrico Molinari
Journal:  Health Qual Life Outcomes       Date:  2014-02-19       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.